Buscar

27/02/2025 Relevance of persistent perfusion deficits on clinical outcomes after successful endovascular treatment: a prospective serial magnetic resonance study
Carbó , AV, Palomar, A, Laredo, C, Werner, M, Dorado, L, Remollo, S, Munuera, J, Puig, J, Silva, Y, de la Ossa, NP, Gomis, M, Bustamante, A, Castaño , C, Muñoz , L, Domenech, S, Terceño , M, Millan, M, Hernández-Pérez, M. Relevance of persistent perfusion deficits on clinical outcomes after successful endovascular treatment: a prospective serial magnetic resonance study. Frontiers in Neurology. 2025; 16DOI:10.3389/fneur.2025.1478240. PMID:40083459. IF:2.800(Q2/5D).
01/02/2025 Randomized Study Comparing First-Line Dual Versus Single-Stent Retriever Technique: TWIN2WIN
Tomasello, A, Moreu, M, Terceño, M, Dinia, L, Caballo, MRB, Requena, M, Jablonska, M, Cendrero, J, Flores, A, Ortega, S, Diana, F, Henandez, D, de Dios, M, Rubiera, M, Garcia-Tornel, A, Rizzo, F, Olivé, M, Pérez-García, C, Gallego, CT, Carmona, T, Rodrigo-Gisbert, M, Molina, C, Ribo, M. Randomized Study Comparing First-Line Dual Versus Single-Stent Retriever Technique: TWIN2WIN. STROKE. 2025; 56(2)DOI:10.1161/STROKEAHA.124.048496. PMID:39704055. IF:8.900(Q1/1D).
01/01/2025 Our experience in petroclival lesions using a contralateral transmaxillary approach
Gras-Cabrerizo, JR, Casasayas-Plass, M, Kolanczak, K, Hernández, FM, Martin, MM, Moreno, EG. Our experience in petroclival lesions using a contralateral transmaxillary approach. NEUROCIRUGIA. 2025; 36(1)DOI:10.1016/j.neucir.2024.10.009. PMID:39672470. IF:0.800(Q3/8D).
01/01/2025 Radial intralesional linear calcifications and focal hyperostosis: key points for diagnosis, extension and point of origin identification of sinonasal inverted papilloma
Granell, E, Cardesin, A, Pallarés, D, Sánchez, R, Gras, JR. Radial intralesional linear calcifications and focal hyperostosis: key points for diagnosis, extension and point of origin identification of sinonasal inverted papilloma. RHINOLOGY. 2025; 63(2)DOI:10.4193/Rhin24.379. PMID:39968850. IF:6.800(Q1/1D).